GRECO, ELIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.853
AS - Asia 1.541
EU - Europa 1.378
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 4
SA - Sud America 4
Totale 11.795
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.838
CN - Cina 829
SG - Singapore 515
FI - Finlandia 324
IT - Italia 284
SE - Svezia 203
DE - Germania 165
UA - Ucraina 148
FR - Francia 113
VN - Vietnam 95
GB - Regno Unito 60
RU - Federazione Russa 29
KR - Corea 28
IN - India 25
NL - Olanda 19
EU - Europa 15
CA - Canada 13
IE - Irlanda 13
IR - Iran 9
HK - Hong Kong 8
JP - Giappone 8
RO - Romania 7
TR - Turchia 7
SI - Slovenia 6
IL - Israele 4
TW - Taiwan 4
ID - Indonesia 3
IQ - Iraq 3
AU - Australia 2
BE - Belgio 2
ES - Italia 2
GR - Grecia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PE - Perù 2
AR - Argentina 1
AZ - Azerbaigian 1
BR - Brasile 1
CH - Svizzera 1
KW - Kuwait 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 11.795
Salva come PNG Salva come JPEG
Città #
Ann Arbor 937
Woodbridge 891
Chandler 863
Houston 754
Fairfield 743
Jacksonville 711
Ashburn 566
Wilmington 422
Singapore 419
Cambridge 329
Boardman 283
Seattle 265
Princeton 230
Des Moines 187
Santa Clara 174
Medford 173
Beijing 170
Nanjing 148
Helsinki 125
Roxbury 102
Dong Ket 94
San Diego 68
Guangzhou 52
Nanchang 48
Shenyang 36
New York 35
Hebei 33
Jiaxing 32
Padova 32
Changsha 28
Tianjin 25
Jinan 22
Gangdong-gu 19
Milan 17
Los Angeles 16
Norwalk 16
Shanghai 15
Zhengzhou 15
London 14
Munich 13
Redwood City 13
Rome 13
Turin 13
Dublin 12
Bologna 10
Falls Church 10
Washington 10
Florence 9
Haikou 9
Kunming 9
Lanzhou 9
Taizhou 9
Dallas 8
Naples 8
Pune 8
Borås 7
Hong Kong 7
Kharkiv 7
Vicenza 7
Cagliari 6
Indiana 6
Rockville 6
Tappahannock 6
Fuzhou 5
Hefei 5
Montreal 5
Ningbo 5
Ogden 5
Amsterdam 4
Bucharest 4
Chengdu 4
Genoa 4
Hangzhou 4
Lappeenranta 4
New Delhi 4
Poggiomarino 4
Redmond 4
Tel Aviv 4
Augusta 3
Detroit 3
Harringay 3
Kilburn 3
Malo 3
Mestre 3
Nürnberg 3
Okazaki 3
Palermo 3
Renon 3
Yenibosna 3
Ankara 2
Atlanta 2
Bari 2
Bassano del Grappa 2
Brescia 2
Campobasso 2
Chicago 2
Chongqing 2
Frankfurt am Main 2
Gallio 2
Geislingen an der Steige 2
Totale 9.444
Salva come PNG Salva come JPEG
Nome #
Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success. 179
La mutazione S59P del gene TNFRSF1A, associata alla TRAPS, causa l'attivazione costitutiva della via del segnale NFkB 161
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 147
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 140
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 130
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications 128
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 126
The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway. 125
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 121
Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. 113
Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals 113
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 111
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 109
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. 109
Serum antibodies anti-H. pylori and anti CagA: a comparison between four different assays. 108
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 107
CD44v10: an antimetastatic membrane glycoprotein for pancreatic cancer 107
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides 105
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 105
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 104
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 104
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 103
Helicobacter pylori infection in children and adults: a single pathogen but different pathology 102
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects 99
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 98
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 97
Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model 96
Quantitative PSA mRNA determination in blood: A biochemical tool for scoring localized prostate cancer 94
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 93
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 91
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 89
Metastatic colo-rectal cancer cells stimulate collagen production by fibroblasts. 88
Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. 87
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 87
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 86
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome 84
Helicobacter pylori virulence genes and host IL-1RN and IL-1b genes interplay in favoring the development of peptic ulcer and intestinal metaplasia 83
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 82
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. 81
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 80
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 80
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 79
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 79
Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblast: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle gene 78
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 78
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 78
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 77
Expression profile of pancreatic cancer cell conditioned myoblast: a 5000 muscle genes microarray analysis 76
Carcinogenetic potential of the WSR cagA region. 75
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 75
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 74
NT-S100A8 effects on cell signalling. 74
Gene therapy with HSV-TK: A promising tool for pancreatic cancer treatment? 74
MALDI-TOF/MS Biomarkers Discovery for Pancreatic Cancer Diagnosis: Emerging Role of Apolipoprotein A1 and Complement C3 74
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 73
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 73
Pancreatic cancer associated diabetogeni peptide induces nitric oxide synthesis in rat hepathocytes 72
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 71
Retrovirus-mediated herpes simplex virus thymidine kinase gene transfer in pancreatic cancer cell lines: an incomplete antitumor effect 71
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 70
A new indirect chemiluminescent immunoassay to measure anti-transglutaminase antibodies: more than a promise 70
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 70
Predisposizione al cancro del pancreas: ruolo dei polimorfismi dei geni XRCC1, XRCC3 e CYP1A1 69
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 69
Interferon gamma (IFNg) and interleukin-10 (IL-10) Haplotypes differently influence Helicobacter pylori infection outcome 69
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 69
Suicide gene therapy with the yeast fusion gene Cytosine Deaminase/Uracil Phosphoribosyltransferase is not enough for pancreatic cancer 68
Gastropanel: a useful screening test in paediatric populations 68
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 68
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 67
Celiac disease diagnosis and monitoring; comparison between chemiluminescence and ELISA anti-transglutaminase and anti-deamidated gliadin peptides measurements. 67
Analogues of vitamin E epitomised by alpha-tochopherol succinate (alpha-TOS) for pancreatic cancer treatment: in vitro results induce caution for in vivo applications 67
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 66
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 66
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS 65
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 65
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 64
The pancreatic cancer derived N-terminal peptide of S100A8 stimulates insulin exocytosis and HEPG2 cell growth. 64
K-ras point mutations detection in pancreatic cancer serum and bile-derived DNA. 64
Urine protein profiling by maldi-tof/ms: normalization and reproducibility. 64
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 64
Carcinogenetic potential of the WSR cagA region of Helicobacter pylori. 63
Gene therapy with HSV-TK: a promising tool for pancreatic cancer treatment? 63
Analogues of vitamin E epitomized by alpha-tocopherol succinate (alpha-tos) for pancreatic cancer treatment: in vitro results induce caution for in vivo application. 62
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 61
Engineering diphteria toxin in pancreatic cancer cells: a promising tool for therapy. 59
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 59
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 59
Polimorfismi del gene TNFa : effetto sulla prognosi e l`esito del cancro del pancreas (CP)Polimorfismi del gene TNFa : effetto sulla prognosi e l`esito del cancro del pancreas (CP) 58
Profilo di espressione di mioblasti condizionati da cellule di cancro del pancreas: analisi mediante microarray di 5000 geni muscolari 58
Carcinogenetic potential of the WSR CagA region of Helicobacter pylori 58
[Biochemical markers of gastric functioning]. 58
Transforming growth factor-beta 1 (TGF-B1) stimulation of pancreatic cancer cells evokes a different invasion pattern in vitro 58
Pancreatic cancer gene therapy with diphteria toxin A (DTA) and its variants CRM176 and CRM197. 58
VKORC1 and CYP2C9 pharmacogenetics: relevance in warfarin maintenance dosing prediction. 56
Isolation and characterization of pancreatic cancer (PC) diabetogenic factor: a 14 aminoacids peptide corresponding to the N-terminal sequence of an S-100 calcium binding protein 56
Identification of new IL12A and IL12B genes polymorphisms as host genetic factors interplaying with H. pylori 56
Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1 56
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 56
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 55
Totale 8.285
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.471
article - articoli 11.854
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.325
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.100 0 0 0 0 0 132 103 194 151 281 146 93
2020/20211.277 63 108 54 161 65 100 14 116 171 89 172 164
2021/20221.462 19 353 77 50 49 108 33 92 72 14 153 442
2022/20231.939 379 211 25 206 339 302 9 110 232 19 71 36
2023/20241.006 36 121 105 73 67 166 70 87 23 56 88 114
2024/20251.257 23 207 226 181 550 70 0 0 0 0 0 0
Totale 11.836